Sentinel Lymph Node Biopsy (SLNB) and axillary surgery are important procedures performed in breast cancer management to determine whether cancer has spread to the lymph nodes. The lymph nodes in the underarm (axilla) are usually the first place where breast cancer may spread. The “sentinel” lymph node is the first node that receives drainage from the tumor area. By identifying and testing this node, surgeons can accurately stage the disease while minimizing unnecessary removal of multiple lymph nodes.
Sentinel Lymph Node Biopsy is a minimally invasive procedure used in early-stage breast cancer patients with no obvious lymph node involvement. During surgery, a special dye and/or radioactive tracer is injected near the tumor to identify the first draining lymph node (sentinel node). This node is then removed and examined under a microscope.
Axillary Lymph Node Dissection involves removal of multiple lymph nodes from the underarm area. It is recommended when cancer has already spread to the sentinel lymph node or when lymph nodes are clinically enlarged before surgery.
While ALND provides detailed staging and better local control in advanced cases, it carries a higher risk of side effects such as arm swelling (lymphedema), numbness, stiffness, and restricted shoulder movement.
After axillary procedures, patients are advised to perform gentle arm exercises to maintain mobility and reduce stiffness. Monitoring for swelling, infection, or wound-related issues is important. Long-term follow-up is essential to detect recurrence and manage any complications early. Proper physiotherapy and lifestyle guidance significantly help in improving recovery and quality of life.